rc_oncneph's profile picture. Medical Dir of Oncnph @bwhkidney @danafarber @harvardmed

APD= Mass Gen Brigham Renal Fellowship @MGBkidneys

VP @onconephsociety 

via @upmc + @mayoclinicneph

Raad Chowdhury, MD, FASN

@rc_oncneph

Medical Dir of Oncnph @bwhkidney @danafarber @harvardmed APD= Mass Gen Brigham Renal Fellowship @MGBkidneys VP @onconephsociety via @upmc + @mayoclinicneph

Maulin has been a huge part of ensuring the American Society of Onconephrology (ASON) has the tools to continue to grow. He is self directed, goal oriented, and communicates exceptionally well in advocating for our organization, all while balancing his clinical and research…

Hi everyone! I’m Maulinkumar Patel, an IMG, Research Assistant at @UTHealthHouston, and Co-chair of website committee @onconephsociety improving onconephrology outreach/education. Thrilled to be applying to #internalmedicine for the #Match2026! AAMC: 16435351 @rc_oncneph

maulinp_96's tweet image. Hi everyone! I’m Maulinkumar Patel, an IMG, Research Assistant at @UTHealthHouston, and Co-chair of website committee @onconephsociety improving onconephrology outreach/education. 

Thrilled to be applying to #internalmedicine for the #Match2026!
AAMC: 16435351

@rc_oncneph


Raad Chowdhury, MD, FASN reposted

Now online in @NDTsocial Obinutuzumab monotherapy is effective in adult pts with nephrotic syndrome and minimal change lesions 🧐OBI monotherapy could be a safe strategy for pts with contraindications or unwilling to use steroids. ▶️academic.oup.com/ndt/article-ab…

hjanders_hans's tweet image. Now online in @NDTsocial

Obinutuzumab monotherapy is effective in adult pts with nephrotic syndrome and minimal change lesions 

🧐OBI monotherapy could be a safe strategy for pts with contraindications or unwilling to use steroids.

▶️academic.oup.com/ndt/article-ab…

Really proud of our @MGBKidneys clinical and Research fellows @ASNKidney. Mentees presented 3 posters (5 in total with collab). Being APD has truly been a tremendous learning experience. The monoclonal work is very dear to us as there is much to learn in renal limited…

rc_oncneph's tweet image. Really proud of our @MGBKidneys clinical and Research fellows @ASNKidney. Mentees presented 3 posters (5 in total with collab).  Being APD has truly been a tremendous learning experience.

The monoclonal work is very dear to us as there is much to learn in renal limited…
rc_oncneph's tweet image. Really proud of our @MGBKidneys clinical and Research fellows @ASNKidney. Mentees presented 3 posters (5 in total with collab).  Being APD has truly been a tremendous learning experience.

The monoclonal work is very dear to us as there is much to learn in renal limited…
rc_oncneph's tweet image. Really proud of our @MGBKidneys clinical and Research fellows @ASNKidney. Mentees presented 3 posters (5 in total with collab).  Being APD has truly been a tremendous learning experience.

The monoclonal work is very dear to us as there is much to learn in renal limited…
rc_oncneph's tweet image. Really proud of our @MGBKidneys clinical and Research fellows @ASNKidney. Mentees presented 3 posters (5 in total with collab).  Being APD has truly been a tremendous learning experience.

The monoclonal work is very dear to us as there is much to learn in renal limited…

Raad Chowdhury, MD, FASN reposted

1. Back from an inspiring #KidneyWk @ASNKidney — sharing highlights from plenary talks, groundbreaking trials, and translational insights shaping the future of nephrology. 👇🧵@MGHTransplant @MGBKidneys


Honored to share this picture with president elect of @ASNKidney Dr. @samirparikhmd who graciously attended the Mass Gen Brigham Reception @MGBKidneys I first met him at @NBLUniv closing ceremony where we shared a dance on stage. More importantly, he took out his phone and…

rc_oncneph's tweet image. Honored to share this picture with president elect of @ASNKidney Dr. @samirparikhmd who graciously attended the Mass Gen Brigham Reception @MGBKidneys 

I first met him at @NBLUniv closing ceremony where we shared a dance on stage. More importantly, he took out his phone and…

Raad Chowdhury, MD, FASN reposted

Working with Abdullal on our recurrence amyloidosis study — hoping for publication soon! @AbdullahJalalMD

SolosVJR's tweet image. Working with Abdullal on our recurrence amyloidosis study — hoping for publication soon! @AbdullahJalalMD

An exciting workshop hosted by our 🇧🇷 onconephrology colleagues with expert speakers from the American Society of Onconephrology. Please attend! @onconephsociety @HerrmannMd @ShrutiGkidney Naoka Murakami

rc_oncneph's tweet image. An exciting workshop hosted by our 🇧🇷  onconephrology colleagues with expert speakers from the American Society of Onconephrology. Please attend!

@onconephsociety 
@HerrmannMd 
@ShrutiGkidney 
Naoka Murakami

We brought together some of the Onconephrology leaders from around the 🌎 @onconephsociety

rc_oncneph's tweet image. We brought together some of the Onconephrology leaders from around the 🌎 

@onconephsociety
rc_oncneph's tweet image. We brought together some of the Onconephrology leaders from around the 🌎 

@onconephsociety
rc_oncneph's tweet image. We brought together some of the Onconephrology leaders from around the 🌎 

@onconephsociety

Raad Chowdhury, MD, FASN reposted

Daratumumab is now FDA and EU approved for treatment of high risk smoldering myeloma. It is recommended level 1 by NCCN. My thoughts: In the AQUILA randomized trial, daratumumab: -Prolonged time to active myeloma -Prolonged time to end organ damage -Delayed time to needing…

VincentRK's tweet image. Daratumumab is now FDA and EU approved for treatment of high risk smoldering myeloma. 
It is recommended level 1 by NCCN. My thoughts: 

In the AQUILA randomized trial, daratumumab:

-Prolonged time to active myeloma 
-Prolonged time to end organ damage 
-Delayed time to needing…

Raad Chowdhury, MD, FASN reposted

Fantastic onconephrology session! Thanks to all the speakers and to everyone who attended! KidneyWk @onconephsociety @asnpublications @JayaKala11 @Nephronette @onconeph @SiskindLeah

HerrmannMd's tweet image. Fantastic onconephrology session! Thanks to all the speakers and to everyone who attended! KidneyWk
@onconephsociety @asnpublications  @JayaKala11 @Nephronette @onconeph @SiskindLeah
HerrmannMd's tweet image. Fantastic onconephrology session! Thanks to all the speakers and to everyone who attended! KidneyWk
@onconephsociety @asnpublications  @JayaKala11 @Nephronette @onconeph @SiskindLeah

The Bo-STONE-ians @MGBKidneys headed to @ASNKidney FIT bowl finals against @hopkinsneph Proud of all these excellent fellows... future of Nephrology is 🌞 #asnkidneywk2025

rc_oncneph's tweet image. The Bo-STONE-ians @MGBKidneys headed to @ASNKidney FIT bowl finals against @hopkinsneph

Proud of all these excellent fellows... future of Nephrology is 🌞 

#asnkidneywk2025

Always a blast hanging with @glomcon Congrats to the Glomcon leadership for being innovative and transformative in teaching kidney medicine across the world! #asnkidneywk2025 @ASNKidney @SaynaNorouzi @BetterCallSeeth @AbdullahJalalMD @Nephro_Sparks @kkalra_22 @PaulHannaMD

rc_oncneph's tweet image. Always a blast hanging with @glomcon 

Congrats to the Glomcon leadership for being innovative and transformative  in teaching kidney medicine across the world!

#asnkidneywk2025 
@ASNKidney 

@SaynaNorouzi @BetterCallSeeth @AbdullahJalalMD @Nephro_Sparks @kkalra_22  @PaulHannaMD…

Another year Moderating the ASN Kidney STARS career guidance panel. We have experts from peds-neph, transplant, private practice, and onconeph. A true testament to the Renaissance thats happening in Nephrology. @ASNKidney #asnkidneywk2025

rc_oncneph's tweet image. Another year Moderating the ASN Kidney STARS career guidance panel.

We have experts from peds-neph, transplant, private practice,  and onconeph. A true testament to the Renaissance thats happening in Nephrology.

@ASNKidney 
#asnkidneywk2025

The Bo-STONE-ians are advancing to the semi finals @ASNKidney FIT Bowl on friday. We appreciate all the support from faculty and alumni that stopped by. @MGBKidneys #asnkidneywk2025

rc_oncneph's tweet image. The Bo-STONE-ians are advancing to the semi finals @ASNKidney FIT Bowl on friday.

We appreciate all the support from faculty and alumni that stopped by. 

@MGBKidneys 
#asnkidneywk2025
rc_oncneph's tweet image. The Bo-STONE-ians are advancing to the semi finals @ASNKidney FIT Bowl on friday.

We appreciate all the support from faculty and alumni that stopped by. 

@MGBKidneys 
#asnkidneywk2025

Happening now #ASN FIT BOWL @MGBKidneys @ASNKidney #asnkidneywk2025 So excited for them!

rc_oncneph's tweet image. Happening now #ASN FIT BOWL

@MGBKidneys 
@ASNKidney
#asnkidneywk2025 
So excited for them!

Its become our annual mentor + mentee dinner at @ASNKidney #asnkidneywk2025 Fine wine, aged bourbon, endless discussions, and closing out a restaurant with Prof. Leung #Onconephrology @onconephsociety

rc_oncneph's tweet image. Its become our annual mentor + mentee dinner at @ASNKidney  #asnkidneywk2025 

Fine wine, aged bourbon, endless discussions,  and closing out a restaurant with Prof. Leung

#Onconephrology @onconephsociety

Loading...

Something went wrong.


Something went wrong.